UC Davis Comprehensive Cancer Center scientist receives $1.4 million federal grant to boost efforts finding a breakthrough treatment for late stage, drug-resistant prostate cancer.
Read MoreBone disease in prostate cancer patients can be devastating, but new research led by UC Davis Comprehensive Cancer Center aims to improve the odds.
Read MoreUC Davis Health urologic surgery chief Christopher Evans is only the ninth American to become an honorary member of the European Association of Urology.
Read MoreIn 2022, the UC Davis School of Medicine scored a record amount of NIH research funding — more than $200 million in grants. This placed UC Davis among the nation’s best medical schools, ranking 32nd nationally.
Read MoreUC Davis Health urologist Allen Gao and his team have developed a molecule, called LX-1, which could help control treatment-resistant prostate cancer.
Read MoreUC Davis Pediatric Urologist Eric Kurzrock devised a new procedure to create graft tissues with functioning blood vessels needed in bladder augmentation surgeries. His innovative method solves the tissue contraction issue, a common problem in bioengineered graft implants.
Read MoreUC Davis Comprehensive Cancer Center researchers found that targeting androgen receptors - a type of protein specific to men - may destroy cancer cells. Focusing on this male protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer in men.
Read More